InvestorsHub Logo
Followers 826
Posts 119435
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Tuesday, 06/18/2019 11:09:39 AM

Tuesday, June 18, 2019 11:09:39 AM

Post# of 866
FDA approves Keytruda monotherapy in third-line SCLC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-104500587.html

This is an accelerated approval based on data from the KEYNOTE-158 and KEYNOTE-028 studies.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News